Actualizado 13/02/2009 19:05
- Comunicado -

Study Proves Longer Prophylactic Therapy With Valcyte Increases Protection Against CMV - the Most Serious Viral Infectio

For further information, please contact: Julia Pipe, International Communications Manager, Roche Transplant, Mobile tel: +41-79-263-9715, Office tel: +41-61-687-4376, E-mail: julia.pipe@roche.com; Helen Swift, Tonic Life Communications, Office tel: +44-20-7798-9924, E-mail: helen.swift@toniclc.com

Contenido patrocinado